Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 1;113(2):199-207.
doi: 10.1093/jnci/djaa078.

Risk of Rare Cancers Among Solid Organ Transplant Recipients

Monica E D'Arcy  1 , David Castenson  2 , Charles F Lynch  3 , Amy R Kahn  4 , Lindsay M Morton  1 , Meredith S Shiels  1 , Ruth M Pfeiffer  1 , Eric A Engels  1
Affiliations

Risk of Rare Cancers Among Solid Organ Transplant Recipients

Monica E D'Arcy et al. J Natl Cancer Inst. .

Abstract

Background: Immunosuppressed solid organ transplant recipients (SOTRs) have elevated rates of certain rare cancers caused by viruses. Evaluating risk of rare cancers among SOTRs may provide etiological clues for additional cancers linked to poor immunity and viral infections.

Methods: We performed a cohort study of 262 455 SOTRs (1987-2014) from the US SOTR registry linked to 17 population-based cancer registries. First cancers in SOTRs were categorized using an established classification scheme based on site and histology. Standardized incidence ratios (SIRs) compared risk in SOTRs with the general population. We used Poisson regression to calculate incidence rate ratios according to immune-related SOTR characteristics, including time since transplant (ie, duration of immunosuppression). All statistical tests were 2-sided.

Results: We examined 694 distinct cancer subtypes, with 33 manifesting statistically significantly elevated SIRs (Bonferroni P < 7.2 × 10-5). All 33 are rare (incidence <6 per 100 000 person-years) and several have known viral etiology (eg, Merkel cell carcinoma: SIR = 24.7, 95% confidence interval [CI] = 20.8 to 29.1). Additional cancers that were increased include squamous cell carcinomas of the lip (SIR range = 18.3-19.8), eye and adnexa (SIR = 13.8, 95% CI = 7.9 to 22.3), salivary gland (SIR = 9.3, 95% CI = 6.1 to 13.5), and nasal cavity and sinuses (SIR = 4.5, 95% CI = 2.8 to 6.8); sebaceous adenocarcinoma (SIR = 34.3, 95% CI = 26.3 to 44.0); malignant fibrous histiocytoma (15.4); and subtypes of bladder, kidney, lung, and colon cancer (SIR range = 3.2-13.3). Incidence of several cancers increased over time since transplant (Ptrend < .05), including squamous cell carcinomas of the lip, salivary gland, and anogenital sites.

Conclusions: SOTRs experience elevated rates of several rare cancers. Because some of these cancers exhibit aggressive behavior with poor outcomes, it is important to further characterize the role of immunity and the potential involvement of oncogenic viruses to improve prevention and treatment.

PubMed Disclaimer

References

    1. Clifford G, Franceschi S.. Immunity, infection, and cancer. Lancet. 2007;370(9581):6–7. - PubMed
    1. Engels EA, Frisch M, Goedert JJ, Biggar RJ, Miller RW.. Merkel cell carcinoma and HIV infection. Lancet. 2002;359(9305):497–498. - PubMed
    1. Gibson TM, Morton LM, Shiels MS, Clarke CA, Engels EA.. Risk of non-Hodgkin lymphoma subtypes in HIV-infected people during the HAART era: a population-based study. AIDS. 2014;28(15):2313–2318. - PMC - PubMed
    1. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM.. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007;370(9581):59–67. - PubMed
    1. Hernandez-Ramirez RU, Shiels MS, Dubrow R, Engels EA.. Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study. Lancet HIV. 2017;4(11):e495–504. - PMC - PubMed

Publication types

MeSH terms